Crestone

Crestone is a company focused on developing small molecule drugs for serious bacterial infections. It offers CRS3123 for the treatment of clostridium difficile infection, oral agents for the treatment of methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococci, and other gram-positive infections, and anti-mycobacterial agents.